Varian Medical Systems, Inc. (NYSE:VAR) Shares Sold by Morgan Stanley

Morgan Stanley lowered its position in Varian Medical Systems, Inc. (NYSE:VAR) by 30.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 200,540 shares of the medical equipment provider’s stock after selling 86,738 shares during the quarter. Morgan Stanley owned about 0.22% of Varian Medical Systems worth $20,587,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also added to or reduced their stakes in VAR. BlackRock Inc. grew its holdings in Varian Medical Systems by 19.9% in the 1st quarter. BlackRock Inc. now owns 10,355,967 shares of the medical equipment provider’s stock worth $1,063,143,000 after buying an additional 1,718,654 shares in the last quarter. Fiera Capital Corp raised its position in shares of Varian Medical Systems by 2.9% during the 1st quarter. Fiera Capital Corp now owns 3,333,823 shares of the medical equipment provider’s stock worth $342,250,000 after buying an additional 94,597 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of Varian Medical Systems by 6.5% during the 1st quarter. Wells Fargo & Company MN now owns 2,392,941 shares of the medical equipment provider’s stock worth $245,658,000 after buying an additional 145,477 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Varian Medical Systems by 1.7% in the fourth quarter. Janus Henderson Group PLC now owns 2,176,072 shares of the medical equipment provider’s stock valued at $309,024,000 after acquiring an additional 35,508 shares in the last quarter. Finally, Mackenzie Financial Corp increased its stake in shares of Varian Medical Systems by 156.8% during the first quarter. Mackenzie Financial Corp now owns 1,503,329 shares of the medical equipment provider’s stock valued at $154,332,000 after acquiring an additional 917,948 shares during the period. 90.84% of the stock is currently owned by institutional investors.

Varian Medical Systems stock opened at $120.42 on Wednesday. Varian Medical Systems, Inc. has a fifty-two week low of $89.62 and a fifty-two week high of $150.06. The firm’s 50 day simple moving average is $119.78 and its 200-day simple moving average is $126.18. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.28 and a quick ratio of 0.97. The company has a market cap of $10.60 billion, a P/E ratio of 44.27, a price-to-earnings-growth ratio of 4.05 and a beta of 1.08.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Monday, May 4th. The medical equipment provider reported $0.85 EPS for the quarter, hitting analysts’ consensus estimates of $0.85. Varian Medical Systems had a net margin of 7.51% and a return on equity of 22.93%. The firm had revenue of $794.50 million during the quarter, compared to analyst estimates of $769.99 million. During the same quarter last year, the business posted $1.05 EPS. The company’s revenue was up 1.9% on a year-over-year basis. On average, analysts expect that Varian Medical Systems, Inc. will post 3.6 EPS for the current fiscal year.

Several brokerages have recently issued reports on VAR. TheStreet cut Varian Medical Systems from a “b-” rating to a “c” rating in a research report on Monday, May 4th. Zacks Investment Research upgraded shares of Varian Medical Systems from a “sell” rating to a “hold” rating and set a $121.00 price target on the stock in a research report on Friday, April 10th. Evercore ISI lowered shares of Varian Medical Systems from an “outperform” rating to an “underperform” rating in a research report on Sunday, April 19th. BTIG Research reissued a “buy” rating and set a $133.00 target price on shares of Varian Medical Systems in a research note on Monday, May 4th. Finally, UBS Group decreased their price target on shares of Varian Medical Systems from $160.00 to $150.00 and set a “buy” rating on the stock in a research report on Tuesday, May 5th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $124.78.

Varian Medical Systems Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Featured Story: What are the advantages of the Stochastic Momentum Index?

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.